Results 151 to 160 of about 4,320,983 (278)

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) [PDF]

, 2000
Alastair Gray
openalex   +1 more source

Financing threatened species management: the costs of single species programmes and the budget constraint [PDF]

In New Zealand total annual funding allows 15 percent of the 2,400 threatened species to be targeted for management. Although management costs are crucial to a conservation organisation's ability to achieve its goals, estimates of costs are not usually ...
Cullen, Ross, Hughey, Kenneth F.D., Moran, Emma   +2 more
core   +1 more source

A cross-national cost-effectiveness analysis of brivaracetam focusing on psychiatric and behavioral adverse effects. [PDF]

Epilepsia Open
Maruyama Y, Kimura H, Nishida T, Ogawa S, Ninomiya K, Ikeda M.   +5 more
europepmc   +1 more source

Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic [PDF]

, 2000
Elizabeth Phillips, Marie Louie, Simon R. Knowles, Andrew E. Simor, Paul Oh   +4 more
openalex   +1 more source

A cost-effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada. [PDF]

Diabetes Obes Metab
Gupta N, Babyak A, Chorbajian A, Tardio V, Ballreich J, Dasgupta K.   +5 more
europepmc   +1 more source

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies

Value in Health, 2018
Ashley A. Leech, David D. Kim, Joshua T. Cohen, P. Neumann   +3 more
semanticscholar   +1 more source

Cost-Effectiveness Analysis of Nirsevimab for Respiratory Syncytial Virus Disease Prevention in Newborns of Hong Kong. [PDF]

Influenza Other Respir Viruses
Wang Y, Rui M, Wei Q, Leung TF, You JHS.
europepmc   +1 more source

Cost-Effectiveness Analysis of Invasive and Noninvasive Tests in High Risk Patients Treated With Amiodarone After Acute Myocardial Infarction

, 1998
Roberto F.E. Pedretti, Giovanni Battista Migliori, Vittorio Mapelli, Gabriele Daniele, Philip J. Podrid, Roberto Tramarin   +5 more
openalex   +1 more source

Cost-effectiveness analysis of screening for congenital Chagas disease in a non-endemic area. [PDF]

Nat Commun
Marraffa P, Dentato M, Nurchis MC, Angheben A, Olivo L, Barbera G, Damiani G, Gianino MM.   +7 more
europepmc   +1 more source

Cost-effectiveness analysis for management of patients with ischemic heart disease

, 1995
Abdulmassih S. Iskandrian
openalex   +1 more source